Top menu navigation

Monday, September 8, 2014

Immune System FTW

Guys. GUYS. Some early results from the trial I'm participating in:


"One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression of HER2 (known as HER2 +3) had no cancer recurrences when they were administered the vaccine after completing trastuzumab (Herceptin), a type of immunotherapy drug known as a monoclonal antibody." (emphasis mine...damn right)



If this is as good as it looks, then it's huge. Fucking huge. Go hug a goddamn scientist.


No comments:

Post a Comment